On November 20, President Trump held a press briefing at which he unveiled two long-awaited actions to reduce prescription drug costs.
Congress and CMS have historically limited coverage of Medicare telehealth services to beneficiaries residing in rural areas and primarily in clinical settings.
As federal legislative efforts to reform prescription drug pricing have stalled and states have felt increasing pressure on their healthcare budgets, a growing number are implementing or considering prescription drug affordability review boards or commissions to reduce drug spending.
After a tumultuous four days, Joe Biden crossed the electoral college threshold to become the 46th President of the United States, a result that the Trump Campaign is challenging with recounts and litigation in several states.
Women are economic and political powerhouses, with the ability to shape economies and sway elections.
As much of the nation’s economic activity ground to a halt at the beginning of the COVID-19 pandemic, millions of people lost jobs and many also lost their job-based healthcare coverage.
The ability to live a healthy life is influenced by a multitude of factors that extend beyond medical care.
On November 10, the Supreme Court is scheduled to hear oral arguments in California v. Texas—formerly referred to as Texas v. United States—a case challenging the constitutionality of the Affordable Care Act (ACA).
In response to the COVID-19 pandemic, state Medicaid agencies have temporarily expanded their telehealth coverage and reimbursement policies in varying degrees.
As part of its COVID-19 response, Congress established the $175 billion PRF under the CARES Act to compensate for lost revenues and help providers respond to the pandemic.